Description

The Harbor Health Care UCITS ETF (WELL) is designed to provide investors with exposure to the sustained expansion and pioneering innovation within the U.S. healthcare system. It seeks to generate returns superior to the broader healthcare market by strategically allocating capital to high-quality companies. These chosen businesses are distinguished by their unique products, advanced technologies, and specialized services, all while meeting the management team's rigorous valuation standards. The fund specifically targets promising, long-term growth areas, including revolutionary fields such as precision oncology, liquid biopsy diagnostics, gene therapy, and therapies for orphan diseases. This ETF is actively overseen by the expert team at Westfield Capital Management.